Шевцов В.И., Макушин В.Д., Ступина Т.А., Степанов М.А. Экспериментальные аспекты изучения репаративной регенерации суставного хряща в условиях туннелирования субхондральной зоны с введением аутологичного костного мозга. Гений ортопедии. 2010; 2: 5-10.

Solheim E., Hegna J., Oyen J., Harlem T., Strand T. Results at 10 to 14 years after osteochondralautografting (mosaicplasty) in articular cartilage defects in the knee. Knee. 2013; 20: 287– 290.

Welsch G.H., Mamisch T.C., Zak L., Blanke M., Olk A., Marlovits S., Trattnig S. Evaluation of cartilage repair tissue after matrix-associated autologous chondrocyte transplantation using a hyaluronic-based or a collagen based scaffold with morphological MOCART scoring and biochemical T2 mapping: preliminary results. Am J Sports Med., 2010; 38(5): 934-942.

Kim M.K., Choi S.W., Kim S. R., Oh I.S., Won M.H. Autologous chondrocyte implantation the knee using fibrin. Knee Surg Sports Traumatol Arthrosc. 2010; 18(4): 528-534.

Benthien J.P., Behrens P. Autologous matrixinduced chondrogenesis (AMIC) combining microfracturing and a collagen i/iii matrix for articular cartilage resurfacing. Cartilage. 2010; 1: 65-68.

Dhollander A., Moens K., van der Maas J., Verdonk P., Almqvist K.F., Victor J. Treatment of Patellofemoral Cartilage Defects in the Knee by Autologous Matrix-Induced Chondrogenesis (AMIC). Acta Orthop. Belg. 2014; 80: 251-259.

Zhai L.J., Zhao K.Q., Wang Z.Q., Feng Y., Xing S.C. Mesenchymal stem cells display different gene expression profiles compared to hyaline and elastic chondrocytes. Int J Clin Exp Med. 2011; 4(1): 81-90.

Tanaka Y. Human mesenchymal stem cells as a tool for joint repair in rheumatoid arthritis. Clin Exp Rheumatol. 2015; 33: 58-62.

Mesenchymal M. Influence of three-dimensional hyaluronic acid stem cell chondrogenesis. Gene Expr. 2009; 15: 243–254. doi:10.1089/ten. tea.2008.0067..
DOI: 10.1089/ten. tea.2008.0067

Pei M., Seidel J., Vunjak-Novakovic G., Freed L.E. Growth factors for sequential cellular de- and re-differentiation in tissue engineering. Biochem. Biophys. Res. Commun. 2002; 294: 149–154. doi:10.1016/S0006-291X(02)00439-4..
DOI: 10.1016/S0006-291X(02)00439-4

Brandl A., Angele P., Roll C., Prantl L., Kujat R., Kinner B. Influence of the growth factors PDGF-BB, TGF-beta1 and bFGF on the replicative aging of human articular chondrocytes during in vitro expansion. J. Orthop. Res. 2010; 28: 354–360. doi:10.1002/jor.21007..
DOI: 10.1002/jor.21007

Duval E., Leclercq S., Elissalde J.-M., Demoor M., Galéra P., Boumédiene K. Hypoxia-inducible factor 1α inhibits the fibroblast-like markers type I and type III collagen during hypoxiainduced chondrocyte redifferentiation: hypoxia not only induces type II collagen and aggrecan, but it also inhibits type I and type III collagen in the hypoxia-inducible factor 1alphadependent redifferentiation of chondrocytes. Arthritis Rheum. 2009; 60: 3038–3048.

doi:10.1002/ art.24851..
DOI: 10.1002/ art.24851

Markway B.D., Cho H., Johnstone B. Hypoxia promotes redifferentiation and suppresses markers of hypertrophy and degeneration in both healthy and osteoarthritic chondrocytes. Arthritis Res. Ther. 2013; 15: R92. doi:10.1186/ ar4272..
DOI: 10.1186/ ar4272

Anitua E., Andia I., Ardanza B., Nurden P., Nurden A.T. Autologous platelets as a source of proteins for healing and tissue regeneration. Thromb Haemost. 2004; 91: 4-15.

Anitua E., Sanchez M., Nurden A.T., Nurden P., Orive G., Andia I. New insights into and novel applications for platelet-rich fibrin therapies. Trends Biotechnol. 2006; 24: 227-234.

Bielecki T.M., Gazdzik T.S., Arendt J., Szczepanski T., Krol W., Wielkoszynski T. Antibacterial effect of autologous platelet gel enriched with growth factors and other active substances: An in vitro study. J Bone Joint Surg Br. 2007; 89: 417-420.

Cervelli V., Gentile P., Grimaldi M. Regenerative surgery: Use of fat grafting combined with platelet-rich plasma for chronic lower-extremity ulcers. Aesthetic Plast Surg. 2009; 33: 340-345.

Mazzocca A.D., McCarthy M.B.R., Chowaniec D.M., et al. Platelet-rich plasma differs according to preparation method and human variability. J Bone Joint Surg Am. 2012; 94: 308–316.

Giusti I., Rughetti A., D’Ascenzo S. et al. Identification of an optimal concentration of platelet gel for promoting angiogenesis in human endothelial cells. Transfusion. 2009; 49: 771–778.

McCarrel T.M., Minas T., Fortier L.A. Optimization of leukocyte concentration in platelet-rich plasma for the treatment of tendinopathy. J Bone Joint Surg Am. 2012; 94: e143.1–e143.8.

Andia I., Abate M. Knee osteoarthritis: hyaluronic acid, platelet-rich plasma or both in association? Expert Opin Biol Ther. 2014; 14(5): 635-649.

Milano G., Sanna Passino E., Deriu L. et al. The effect of platelet rich plasma combined with microfractures on the treatment of chondral defects: an experimental study in a sheep model. Osteoarthritis Cartilage. 2010; 18: 971– 980.

Qi Y.Y., Chen X., Jiang Y.Z. et al. Local delivery of autologous platelet in collagen matrix simulated in situ articular cartilage repair. Cell Transplant. 2009; 18: 1161–1169.

Sun Y., Feng Y., Zhang C.Q. et al. The regenerative effect of platelet-rich plasma on healing in large osteochondral defects. Int Orthop. 2010; 34: 589–597.

Egemen Altan, Kerem Aydin, Omer Erkocak, Hakan Senaran, Serdar Ugras. The effect of platelet-rich plasma on osteochondral defects treated with mosaicplasty. International Orthopaedics (SICOT). 2014; 38: 1321–1328. doi: 10.1007/s00264-013-2275-9..
DOI: 10.1007/s00264-013-2275-9

Kon E., Filardo G., Delcogliano M. et al. Platelet autologous growth factors decrease the osteochondral regeneration capability of a collagenhydroxyapatite scaffold in a sheep model. BMC Musculoskelet Disord. 2010; 11: 220.

Serra C.I., Soler C., Carrillo J.M. et al. Effect of autologous platelet-rich plasma on the repair of full-thickness articular defects in rabbits. Knee Surg Sports Traumatol Arthrosc. 2013; 21: 1730–1736.

Khoshbin A., Leroux T., Wasserstein D. et al. The efficacy of platelet-rich plasma in the treatment of symptomatic knee osteoarthritis: a systematic review with quantitative synthesis. Arthroscopy. 2013; 29: 2037–2048.

Chang K.V., Hung C.Y., Aliwarga F. et al. Comparative effectiveness of platelet-rich plasma injections for treating knee joint cartilage degenerative pathology: a systematic review and meta-analysis. Arch Phys Med Rehabil. 2014; 95: 562–575.

Laudy A.B.M., Bakker E.W.P., Rekers M. et al. Efficacy of platelet-rich plasma injections in osteoarthritis of the knee: a systematic review and meta-analysis. Br J Sports Med. 2015; 49: 657–672.

Patel S., Dhillon M.S., Aggarwal S., Marwaha N., Jain A. Treatment with platelet-rich plasma is more effective than placebo for knee osteoarthritis: A prospective, double-blind, randomized trial. Am J Sports Med. 2013; 41(2): 356-364.

Campbell K.A., Saltzman B.M., Mascarenhas R. et al. Does intra-articular platelet-rich plasma injection provide clinically superior outcomes compared with other therapies in the treatment of knee osteoarthritis? A systematic review of overlapping meta-analyses. Arthroscopy. 2015; 31: 2213–2221.

Riboh J.C., Saltzman B.M., Yanke A.B. et al. Effect of leukocyte concentration on the efficacy of platelet-rich plasma in the treatment of knee osteoarthritis. Am J Sports Med. 2015.

pii:0363546515580787. [Epub ahead of print].

Маланин Д.А., Новочадов В.В., Демкин С.А. и соавт. Обогащенная тромбоцитами аутологичная плазма в лечении пациентов с гонартрозом III стадии. Травматология и ортопедия России. 2014;3(73):52-59.

Filardo G., Kon E., Buda R., Timoncini A. Platelet-rich plasma intra-articular knee injections for the treatment of degenerative cartilage lesions and osteoarthritis. Knee Surg Sports Traumatol Arthrosc. 2011;19:528–535. doi: 10.1007/s00167-010-1238-6..
DOI: 10.1007/s00167-010-1238-6

Sanchez M., Anitua E., Orive G., Mujika I., Andia I. Platelet- rich therapies in the treatment of orthopaedic sport injuries. Sports Med. 2009;39:345–354.